Leading Pharma, LLC recalls

1 recalls.

• Furosemide Tablets recall (Leading Pharma, LLC)
  DrugClass IIReported April 29, 2026 · CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.